CONMED Corporation revised earnings guidance for the full year 2022. The Company is narrowing its revenue guidance for the full year 2022 and now expects revenue between $1.1 billion and $1.115 billion compared to its prior guidance of between $1.095 billion and $1.140 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.01 USD | -1.82% | -9.62% | -36.07% |
Apr. 24 | Transcript : CONMED Corporation, Q1 2024 Earnings Call, Apr 24, 2024 | |
Apr. 24 | Earnings Flash (CNMD) CONMED CORPORATION Posts Q1 Revenue $312.3M, vs. Street Est of $306.7M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.07% | 2.2B | |
-2.89% | 187B | |
-2.43% | 108B | |
-4.10% | 67.71B | |
+11.10% | 53.07B | |
+15.86% | 47.36B | |
+6.01% | 39.73B | |
+9.55% | 28.56B | |
+1.85% | 26.55B | |
+15.97% | 25.13B |
- Stock Market
- Equities
- CNMD Stock
- News CONMED Corporation
- CONMED Corporation Revises Earnings Guidance for the Full Year 2022